Understanding the impact of distance and disadvantage on lung cancer care and outcomes: a study protocol.

COM-B model Informal carer Lung cancer Oncology Patient experience Qualitative research Rural health Urban health

Journal

BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 27 02 2024
accepted: 25 07 2024
medline: 3 8 2024
pubmed: 3 8 2024
entrez: 2 8 2024
Statut: epublish

Résumé

Lung cancer is the third most common cancer in the UK and the leading cause of cancer mortality globally. NHS England guidance for optimum lung cancer care recommends management and treatment by a specialist team, with experts concentrated in one place, providing access to specialised diagnostic and treatment facilities. However, the complex and rapidly evolving diagnostic and treatment pathways for lung cancer, together with workforce limitations, make achieving this challenging. This place-based, behavioural science-informed qualitative study aims to explore how person-related characteristics interact with a person's location relative to specialist services to impact their engagement with the optimal lung pathway, and to compare and contrast experiences in rural, coastal, and urban communities. This study also aims to generate translatable evidence to inform the evidence-based design of a patient engagement intervention to improve lung cancer patients' and informal carers' participation in and experience of the lung cancer care pathway. A qualitative cross-sectional interview study with people diagnosed with lung cancer < 6 months before recruitment (in receipt of surgery, radical radiotherapy, or living with advanced disease) and their informal carers. Participants will be recruited purposively from Barts Health NHS Trust and United Lincolnshire Hospitals NHS Trusts to ensure a diverse sample across urban and rural settings. Semi-structured interviews will explore factors affecting individuals' capability, opportunity, and motivation to engage with their recommended diagnostic and treatment pathway. A framework approach, informed by the COM-B model, will be used to thematically analyse facilitators and barriers to patient engagement. The study aligns with the current policy priority to ensure that people with cancer, no matter where they live, can access the best quality treatments and care. The evidence generated will be used to ensure that lung cancer services are developed to meet the needs of rural, coastal, and urban communities. The findings will inform the development of an intervention to support patient engagement with their recommended lung cancer pathway. The study received NHS Research Ethics Committee (Ref: 23/SC/0255) and NHS Health Research Authority (IRAS ID 328531) approval on 04/08/2023. The study was prospectively registered on Open Science Framework (16/10/2023; https://osf.io/njq48 ).

Sections du résumé

BACKGROUND BACKGROUND
Lung cancer is the third most common cancer in the UK and the leading cause of cancer mortality globally. NHS England guidance for optimum lung cancer care recommends management and treatment by a specialist team, with experts concentrated in one place, providing access to specialised diagnostic and treatment facilities. However, the complex and rapidly evolving diagnostic and treatment pathways for lung cancer, together with workforce limitations, make achieving this challenging. This place-based, behavioural science-informed qualitative study aims to explore how person-related characteristics interact with a person's location relative to specialist services to impact their engagement with the optimal lung pathway, and to compare and contrast experiences in rural, coastal, and urban communities. This study also aims to generate translatable evidence to inform the evidence-based design of a patient engagement intervention to improve lung cancer patients' and informal carers' participation in and experience of the lung cancer care pathway.
METHODS METHODS
A qualitative cross-sectional interview study with people diagnosed with lung cancer < 6 months before recruitment (in receipt of surgery, radical radiotherapy, or living with advanced disease) and their informal carers. Participants will be recruited purposively from Barts Health NHS Trust and United Lincolnshire Hospitals NHS Trusts to ensure a diverse sample across urban and rural settings. Semi-structured interviews will explore factors affecting individuals' capability, opportunity, and motivation to engage with their recommended diagnostic and treatment pathway. A framework approach, informed by the COM-B model, will be used to thematically analyse facilitators and barriers to patient engagement.
DISCUSSION CONCLUSIONS
The study aligns with the current policy priority to ensure that people with cancer, no matter where they live, can access the best quality treatments and care. The evidence generated will be used to ensure that lung cancer services are developed to meet the needs of rural, coastal, and urban communities. The findings will inform the development of an intervention to support patient engagement with their recommended lung cancer pathway.
PROTOCOL REGISTRATION BACKGROUND
The study received NHS Research Ethics Committee (Ref: 23/SC/0255) and NHS Health Research Authority (IRAS ID 328531) approval on 04/08/2023. The study was prospectively registered on Open Science Framework (16/10/2023; https://osf.io/njq48 ).

Identifiants

pubmed: 39095781
doi: 10.1186/s12885-024-12705-9
pii: 10.1186/s12885-024-12705-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

942

Subventions

Organisme : Cancer Research UK
ID : PICATR-2022/100019
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PICATR-2022/100017
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PICATR-2022/100019
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PICATR-2022/100019
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

Oliver AL. Lung Cancer: Epidemiology and Screening. Surg Clin North Am. 2022;102(3):335–44.
pubmed: 35671760 doi: 10.1016/j.suc.2021.12.001
Cancer Research UK. Lung Cancer Statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer . Accessed 19 Nov 2023.
NHS England. National Optimal Lung Cancer Pathway: For suspected and confirmed lung cancer: Referral to treatment. https://www.cancerresearchuk.org/sites/default/files/national_optimal_lung_pathway_aug_2017.pdf . Accessed 20 Nov 2023.
Otty Z, Brown A, Sabesan S, Evans R, Larkins S. Optimal care pathways for people with Lung Cancer- a scoping review of the literature. Int J Integr Care. 2020;20(3):14.
pubmed: 33041731 pmcid: 7528692 doi: 10.5334/ijic.5438
Conibear J, Nossiter J, Foster C, West D, Cromwell D, Navani N. The National Lung Cancer audit: the impact of COVID-19. Clin Oncol. 2022;34(11):701–7.
doi: 10.1016/j.clon.2022.09.002
Cancer Research Uk. Deprivation gradient for cancer mortality https://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality/deprivation-gradient#heading-One . Accessed 19 Nov 2023.
Forrest LF, Adams J, Rubin G, White M. The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study. Thorax. 2015;70(2):138–45.
pubmed: 24923873 doi: 10.1136/thoraxjnl-2014-205517
Crosbie PAJ, Gabe R, Simmonds I, Hancock N, Alexandris P, Kennedy M et al. Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial. Eur Respir J 2022;60(5).
Payne NWS, Brown KF, Delon C, Kotrotsios Y, Soerjomataram I, Shelton J. Socio-economic deprivation and cancer incidence in England: quantifying the role of smoking. PLoS ONE. 2022;17(9):e0272202.
pubmed: 36129905 pmcid: 9491592 doi: 10.1371/journal.pone.0272202
Office for National Statitics. Likelihood of smoking four times higher in England’s most deprived areas then least deprived. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/articles/likelihoodofsmokingfourtimeshigherinenglandsmostdeprivedareasthanleastdeprived/2018-03-14 . Accessed 25 Nov 2023.
Higgins T, Larson E, Schnall R. Unraveling the meaning of patient engagement: a concept analysis. Patient Educ Couns. 2017;100(1):30–6.
pubmed: 27665500 doi: 10.1016/j.pec.2016.09.002
Petty WJ, Paz-Ares L. Emerging strategies for the treatment of small cell lung Cancer: a review. JAMA Oncol. 2023;9(3):419–29.
pubmed: 36520421 doi: 10.1001/jamaoncol.2022.5631
Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891.
pubmed: 37979378 doi: 10.1016/j.biopha.2023.115891
Lynch C, Harrison S, Butler J, Baldwin DR, Dawkins P, van der Horst J, et al. An International Consensus on actions to improve Lung Cancer Survival: a modified Delphi Method among Clinical experts in the International Cancer Benchmarking Partnership. Cancer Control. 2022;29:10732748221119354.
pubmed: 36269109 pmcid: 9596933 doi: 10.1177/10732748221119354
Davis RE, Jacklin R, Sevdalis N, Vincent CA. Patient involvement in patient safety: what factors influence patient participation and engagement? Health Expect. 2007;10(3):259–67.
pubmed: 17678514 pmcid: 5060404 doi: 10.1111/j.1369-7625.2007.00450.x
World Health Organisation. Patient Engagement: Technical Series on Safer Primary Care. https://iris.who.int/bitstream/handle/10665/252269/9789241511629-eng.pdf?sequence=1 Accessed 20 Nov 2023.
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.
pubmed: 21513547 pmcid: 3096582 doi: 10.1186/1748-5908-6-42
United Kingdom Lung Cancer Coalition. Pathways Matter: A review of the implementation of the national optimal lung cancer pathway. https://www.uklcc.org.uk/sites/default/files/2021-06/UKLCC-Pathways-Matter-Report.pdf . Accessed 20 Nov 2023.
Health Education England. Care Navigation: A Competency Framework. 2016. https://www.hee.nhs.uk/sites/default/files/documents/Care%20Navigation%20Competency%20Framework_Final.pdf . Accessed 27 Dec 2023.
Bird W. Improving health in coastal communities. BMJ. 2021;374:n2214.
pubmed: 34535467 doi: 10.1136/bmj.n2214
Philip L, Williams F. Remote rural home based businesses and digital inequalities: understanding needs and expectations in a digitally underserved community. J Rural Stud. 2019;68:306–18.
doi: 10.1016/j.jrurstud.2018.09.011
Witty C. Chief Medical Officer’s annual report 2021: Health in coastal communities. https://assets.publishing.service.gov.uk/media/60f98750e90e0703bbd94a41/cmo-annual_report-2021-health-in-coastal-communities-accessible.pdf . 2021. Accessed 10 Nov 2023.
Witty C. Chief Medical Officer’s annual report 2023: Health in an ageing society. https://assets.publishing.service.gov.uk/media/65562ff2d03a8d000d07faa6/chief-medical-officers-annual-report-2023-web-accessible.pdf . 2023. Accessed 10 Nov 2023.
Department for Environment Food & Rural Affairs: Delivering for rural England - the second report on rural proofing. 2022. https://assets.publishing.service.gov.uk/media/6312001de90e077b73f776d7/Delivering_for_rural_England_-_the_second_rural_proofing_report.pdf . Accessed 27 December 2023.
Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open. 2015;5(5):e007328.
pubmed: 25956762 pmcid: 4431167 doi: 10.1136/bmjopen-2014-007328
Feng X, Feng Z, Astell-Burt T. Perceived public transport infrastructure modifies the association between public transport use and mental health: multilevel analyses from the United Kingdom. PLoS ONE. 2017;12(8):e0180081.
pubmed: 28813422 pmcid: 5558919 doi: 10.1371/journal.pone.0180081
McPeake K, Jeanes L, Nelson D, Selby P, Cooke S, Gussy M, et al. Developing a ‘Living with Cancer’ programme in a rural and coastal setting: experiences of collaborative and innovative co-production across an Integrated Health System. J Cancer Policy. 2023;38:100452.
pubmed: 37931888 doi: 10.1016/j.jcpo.2023.100452
Charter L, Scully R, Laidlaw A. The word that comes to mind is polymath’: medical students’ perceptions of rural postgraduate careers. Rural Remote Health. 2021;21(3):6750.
pubmed: 34412505
Maclaren AS, Locock L, Skea Z. Valuing place in doctors’ decisions to work in remote and rural locations. Future Healthc J. 2022;9(3):248–51.
pubmed: 36561806 pmcid: 9761459
Ministry of Housing Communities & Local Government. The English Indices of Deprivation 2019 (IoD2019). 2019. https://assets.publishing.service.gov.uk/media/5d8e26f6ed915d5570c6cc55/IoD2019_Statistical_Release.pdf . Accessed 11 Nov 2023.
Fecht D, Fortunato L, Morley D, Hansell AL, Gulliver J. Associations between urban metrics and mortality rates in England. Environ Health. 2016;15(Suppl 1Suppl 1):34.
pubmed: 26960289 pmcid: 4895780 doi: 10.1186/s12940-016-0106-3
Department for Environment Food & Rural Affairs. Key Findings, Statistical digest of rural England. 2024. https://www.gov.uk/government/statistics/key-findings-statistical-digest-of-rural-england/key-findings-statistical-digest-of-rural-england . Accessed 12 Nov 2023.
Kelly FJ, Fussell JC. Air pollution and public health: emerging hazards and improved understanding of risk. Environ Geochem Health. 2015;37(4):631–49.
pubmed: 26040976 pmcid: 4516868 doi: 10.1007/s10653-015-9720-1
Public Health England. Improving access to greenspace: A new review for 2020. 2020. https://assets.publishing.service.gov.uk/media/5f202e0de90e071a5a924316/Improving_access_to_greenspace_2020_review.pdf . Accessed 13 Nov 2023.
Nijman J, Wei YD. Urban inequalities in the 21st century economy. Appl Geogr. 2020;117:102188.
pubmed: 32287517 pmcid: 7124478 doi: 10.1016/j.apgeog.2020.102188
O’Dowd EL, Merriel SWD, Cheng VWT, Khan S, Howells LM, Gopal DP, et al. Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review. BMC Cancer. 2023;23(1):820.
pubmed: 37667231 pmcid: 10476302 doi: 10.1186/s12885-023-11300-8
Nelson D, Selby P, Kane R, Harding-Bell A, Kenny A, McPeake K, et al. Implementing the European code of cancer practice in rural settings. J Cancer Policy. 2024;39:100465.
pubmed: 38184144 doi: 10.1016/j.jcpo.2023.100465
Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061.
pubmed: 34593508 pmcid: 8482308 doi: 10.1136/bmj.n2061
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
pubmed: 17872937 doi: 10.1093/intqhc/mzm042
Rocque GB, Williams CP, Miller HD, Azuero A, Wheeler SB, Pisu M, et al. Impact of Travel Time on Health Care costs and Resource Use by Phase of Care for older patients with Cancer. J Clin Oncol. 2019;37(22):1935–45.
pubmed: 31184952 pmcid: 6804875 doi: 10.1200/JCO.19.00175
Kaushik V, Walsh CA. Pragmatism as a Research Paradigm and its implications for Social Work Research. Social Sci. 2019;8(9):255.
doi: 10.3390/socsci8090255
Patton M. Qualitative Research and Evaluation Methods, 3rd Edition edn: Thousand Oaks: Sage Publications; 2002.
Benoot C, Hannes K, Bilsen J. The use of purposeful sampling in a qualitative evidence synthesis: a worked example on sexual adjustment to a cancer trajectory. BMC Med Res Methodol. 2016;16:21.
pubmed: 26891718 pmcid: 4757966 doi: 10.1186/s12874-016-0114-6
Dworkin SL. Sample size policy for qualitative studies using in-depth interviews. Arch Sex Behav. 2012;41(6):1319–20.
pubmed: 22968493 doi: 10.1007/s10508-012-0016-6
Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523.
pubmed: 34785096 doi: 10.1016/j.socscimed.2021.114523
Jenkins EK, Slemon A, Haines-Saah RJ, Oliffe J. A guide to multisite qualitative analysis. Qual Health Res. 2018;28(12):1969–77.
pubmed: 30024317 doi: 10.1177/1049732318786703
Philbin MM, Parish CL, Kinnard EN, Reed SE, Kerrigan D, Alcaide ML, Cohen MH, Sosanya O, Sheth AN, Adimora AA, Cocohoba J. Multisite study of women living with HIV’s perceived barriers to, and interest in, long-acting injectable antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr. 2020;84(3):263–70.
pubmed: 32530905 doi: 10.1097/QAI.0000000000002337
Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by Information Power. Qual Health Res. 2016;26(13):1753–60.
pubmed: 26613970 doi: 10.1177/1049732315617444
Bergen N, Labonté R. Everything is perfect, and we have no problems: detecting and limiting Social Desirability Bias in qualitative research. Qual Health Res. 2020;30(5):783–92.
pubmed: 31830860 doi: 10.1177/1049732319889354
Morgan DL, Ataie J, Carder P, Hoffman K. Introducing dyadic interviews as a method for collecting qualitative data. Qual Health Res. 2013;23(9):1276–84.
pubmed: 23925406 doi: 10.1177/1049732313501889
Ritchie J, Spencer L, Bryman A, Burgess RG. Analysing qualitative data. In.: Routledge, London; 1994.
Berger R. Now I see it, now I don’t: researcher’s position and reflexivity in qualitative research. Qualitative Res. 2015;15(2):219–34.
doi: 10.1177/1468794112468475
Dodgson JE. Reflexivity in qualitative research. J Hum Lactation. 2019;35(2):220–2.
doi: 10.1177/0890334419830990
Levit LA, Byatt L, Lyss AP, Paskett ED, Levit K, Kirkwood K, et al. Closing the Rural Cancer Care Gap: three institutional approaches. JCO Oncol Pract. 2020;16(7):422–30.
pubmed: 32574128 doi: 10.1200/OP.20.00174
Cancer Research UK. Making Discoveries. Driving Progress. Bringing Hope. Our Research Strategy. 2022. https://www.cancerresearchuk.org/sites/default/files/cancer_research_uk_-_our_research_strategy.pdf . Accessed 22 Nov 2023.
Ali N, Nelson D, McInnerney D, Quaife SL, Laparidou D, Selby P, et al. A systematic review on the qualitative experiences of people living with lung cancer in rural areas. Support Care Cancer. 2024;32(3):144.
pubmed: 38316704 pmcid: 10844412 doi: 10.1007/s00520-024-08342-4
Brice SN, Harper P, Crosby T, Gartner D, Arruda E, England T, et al. Factors influencing the delivery of cancer pathways: a summary of the literature. J Health Organ Manag. 2021;35(9):121–39.
pubmed: 33818048 pmcid: 9136872 doi: 10.1108/JHOM-05-2020-0192
O’Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 2019;9(8):e029954.
pubmed: 31420394 pmcid: 6701588 doi: 10.1136/bmjopen-2019-029954

Auteurs

Daisy McInnerney (D)

Centre for Cancer Screening, Prevention, and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

Samantha L Quaife (SL)

Centre for Cancer Screening, Prevention, and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

Samuel Cooke (S)

Lincoln Institute for Rural and Coastal Health, College of Health and Science, University of Lincoln, Lincoln, UK.

Lucy Mitchinson (L)

Centre for Cancer Screening, Prevention, and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. l.mitchinson@qmul.ac.uk.

Zara Pogson (Z)

Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln, UK.

William Ricketts (W)

Barts Health NHS Trust, London, UK.

Adam Januszewski (A)

Barts Health NHS Trust, London, UK.

Anna Lerner (A)

Barts Health NHS Trust, London, UK.

Dawn Skinner (D)

Pilgrim Hospital, United Lincolnshire Hospitals NHS Trust, Boston, UK.

Sarah Civello (S)

Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln, UK.

Ros Kane (R)

School of Health and Social Care, College of Health and Science, University of Lincoln, Lincoln, UK.

Ava Harding-Bell (A)

Swineshead Patient Participation Group, Swineshead Medical Group, Boston, UK.

Lynn Calman (L)

Centre for Psychosocial Research in Cancer, School of Health Sciences, University of Southampton, Southampton, UK.

Peter Selby (P)

School of Medicine, University of Leeds, Leeds, UK.
Lincoln Medical School, College of Health and Science, University of Lincoln, Lincoln, UK.

Michael D Peake (MD)

Glenfield Hospital, University of Leicester, Leicester, UK.
Cancer Research UK, London, UK.

David Nelson (D)

Lincoln Institute for Rural and Coastal Health, College of Health and Science, University of Lincoln, Lincoln, UK.
Macmillan Cancer Support, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH